Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon

Non-FDG PET Tracers in Oncology

Nov. 29, 4:30-6:00 p.m. | S505AB

This session covers a range of topics related to the latest developments in radiotracers. It offers a review of major biological targets that could be useful for imaging in prostate and other cancers, and showcases the potential of a variety of non-FDG tracers.

Screening for Diseases: Current Controversies

Wednesday, Nov. 28, 4:30-6:00 p.m. | E450A

A panel of expert speakers reviews the benefits, harms and controversies associated with screening for lung and breast cancer.

Essentials in Oncologic Imaging: What Radiologists Need to Know: Part II

Wednesday, Nov. 28, 2:00-5:45 p.m. | S402AB

This interactive, case-based session provides a practical, clinically-relevant summary of key imaging issues in common cancers , includes an overview of current cancer-related terminology and describes how imaging can optimally assess and measure tumor treatment response.

Advanced Imaging Techniques for Detection and Staging of Prostate Cancer

Wednesday, Nov. 28, 10:30 a.m. – 12:15 p.m. | E353C

Speakers discuss a wide variety of topics, including various MRI techniques and the role of imaging in active surveillance of prostate cancer.

Essentials in Oncologic Imaging: What Radiologists Need to Know: Part I

Wednesday, Nov. 28, 8:30 a.m. – 12:15 p.m. | S402AB

This interactive, case-based session provides a practical, clinically-relevant summary of key imaging issues in common cancers , includes an overview of current cancer-related terminology and describes how imaging can optimally assess and measure tumor treatment response.

Essentials in Oncologic Imaging: What Radiologists Need to Know: Part I

Wednesday, Nov. 28, 8:30 a.m. – 12:15 p.m. | S402AB

This interactive, case-based session provides a practical, clinically-relevant summary of key imaging issues in common cancers , includes an overview of current cancer-related terminology and describes how imaging can optimally assess and measure tumor treatment response.

Beyond the pink: Are we there yet?

October, National Breast Cancer Awareness Month, typically brings a bevy of pink ribbons, t-shirts and more. This year, the color pink seems to have exploded. It’s a marketing success story, but will it translate into actions that make a difference?

Lung Cancer Screening: Update 2012

Monday, Nov. 26, 8:30-10:00 a.m.| E405A
This session presents the issues involved in planning and establishing a lung cancer screening program. It features a discussion of the risks and benefits of screening and a discussion of the National Lung Screening Trial, and also will cover the resources needed to undertake a screening program.

Displaying 777 - 784 of 2554

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.